Inclusion Criteria:  T1-T4b N0-1 at diagnosis and subsidiary of neoadjuvant treatment Post-CT SLN with ≤2 macrometastasis If N + pre-neoadjuvant treatment also include micrometastases Post-CT axillary ultrasound, BEDI <4 in all visualized nodes Complete at least 3 months of neoadjuvant chemotherapy and 6 months of endocrine treatment.  Exclusion Criteria:  Inflammatory carcinoma or cN2 ypN0 History of breast surgery for ipsilateral cancer History of other cancer in the last 5 years, except squamous carcinoma of the skin